Aaron Ortiz

Aaron Ortiz is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as the Director of Xeno Manufacturing Operations at United Therapeutics Corporation since September 2019. Previously, Aaron held the position of Director of Microbiology at Glenmark Pharmaceuticals from October 2017 to September 2019. Aaron's experience at GlaxoSmithKline Pharma GmbH spanned from July 2011 to October 2017, where roles included Quality Manager of Microbiology and Manager of Quality Control Microbiology. Prior to that, Aaron worked at Human Genome Sciences from April 2001 to June 2011, progressing through various roles including Supervisor, Quality Control Microbiology and Validation Engineer. Aaron holds a Bachelor of Arts degree in Biology from Elmira College, earned between 1996 and 2000.